IRIS
FANIN, Renato
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.904
EU - Europa 5.458
AS - Asia 1.414
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 18
SA - Sud America 4
OC - Oceania 2
Totale 28.832
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.775
UA - Ucraina 2.089
DE - Germania 862
CN - Cina 841
IT - Italia 678
FI - Finlandia 633
SE - Svezia 473
IE - Irlanda 367
SG - Singapore 176
TR - Turchia 168
CA - Canada 125
GB - Regno Unito 107
FR - Francia 89
VN - Vietnam 85
IN - India 60
IR - Iran 40
RU - Federazione Russa 40
CZ - Repubblica Ceca 24
BE - Belgio 22
EU - Europa 18
TG - Togo 18
NL - Olanda 15
KR - Corea 14
PL - Polonia 11
JP - Giappone 10
RO - Romania 10
EG - Egitto 8
HK - Hong Kong 8
CH - Svizzera 7
ES - Italia 7
RS - Serbia 7
ID - Indonesia 6
ZA - Sudafrica 6
BG - Bulgaria 4
BR - Brasile 4
AT - Austria 3
IL - Israele 3
MX - Messico 3
AU - Australia 2
GR - Grecia 2
LU - Lussemburgo 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
GL - Groenlandia 1
HU - Ungheria 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
NO - Norvegia 1
PT - Portogallo 1
Totale 28.832
Salva come PNG Salva come JPEG
Città #
Fairfield 2.992
Woodbridge 2.884
Houston 1.963
Ann Arbor 1.893
Jacksonville 1.410
Ashburn 1.291
Seattle 1.215
Wilmington 1.128
Chandler 1.108
Cambridge 980
Dearborn 885
Boardman 484
Beijing 421
Princeton 381
Dublin 367
Udine 276
San Diego 187
Izmir 168
Singapore 124
Ogden 99
Ottawa 97
Norwalk 86
Dong Ket 84
Des Moines 75
Hefei 62
Nanjing 55
Redmond 50
Trieste 46
Kunming 41
New York 41
Dallas 37
Milan 34
Regensburg 29
Simi Valley 29
Los Angeles 27
Guangzhou 23
Jinan 23
Nanchang 23
Brussels 22
Hangzhou 21
Helsinki 21
Saint Petersburg 21
Leawood 20
Toronto 19
Grafing 18
Lomé 18
Phoenix 15
Venezia 15
Fuzhou 14
Shenyang 14
Andover 13
Falls Church 13
Augusta 12
Chengdu 12
San Mateo 12
Wuhan 12
Brno 11
Monmouth Junction 11
Rome 11
Washington 11
Zanjan 11
Ardabil 10
Warsaw 10
Duino-Aurisina 9
Frankfurt am Main 9
Hyderabad 9
Hong Kong 8
Indiana 8
Zhengzhou 8
Belgrade 7
Cairo 7
Hebei 7
London 7
Redwood City 7
Tokyo 7
Amsterdam 6
Chongqing 6
Modderfontein 6
Montreal 6
Mumbai 6
Olomouc 6
Prague 6
Santa Clara 6
Zurich 6
Changsha 5
Edinburgh 5
Horia 5
Munich 5
Murano 5
Ningbo 5
Pune 5
Spinea 5
Buffalo 4
Chaoyang 4
Florence 4
Henderson 4
Lappeenranta 4
Madrid 4
Quzhou 4
Sacramento 4
Totale 21.704
Salva come PNG Salva come JPEG
Nome #
Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy 233
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party 199
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 173
Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with hematological malignancies 153
Central nervous system fungal infections in allogeneic stem cell transplantation. Outcome of 24 recent cases and literature review 147
Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia. 144
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery 144
Atypical haemolytic-uraemic syndrome at the onset of acute promyelocytic leukaemia. 140
The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation 138
Abdominal abscess and Hafnia alvei septicemia occurring during the aplastic phase after autologous stem-cell transplantation in a patient with diffuse large B-cell lymphoma. 136
Low-dose rituximab in adult patients with primary immune thrombocytopenia. 136
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 134
Multipotent Progenitor Cells Are Present in Human Peripheral Blood. 134
Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia 133
Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrations. 132
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 132
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. 129
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 129
Activity of all-trans-retinoic acid in a case of central nervous system extramedullary relapse of acute promyelocytic leukemia 128
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years 128
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 127
Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib 127
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response. 127
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells 126
Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia 125
Efficacy and safety of rituximab in type II mixed cryoglobulinemia. 124
Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry. 123
Management of immune thrombocytopenia in elderly patients 123
Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization. 122
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 122
Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma. 120
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results 120
“Overexpression of multidrug resistance-associated P-170 glycoprotein in acute non lymphocytic leukemia”. 118
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 118
Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre study. 117
Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases 117
Granulocyte colony-stimulating factor (G-CSF) allows the delivery of effective doses of CHOP and CVP regimens in non-Hodgkin lymphomas. 117
Bendamustine in chronic lymphocytic leukemia: Outcome according to different clinical and biological prognostic factors in the everyday clinical practice. 116
Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous Transplantation 116
Autologous stem cell transplantation in chronic carriers of hepatitis B virus and hepatitis C virus affected by onco-hematologic diseases. 116
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)” 115
ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission 115
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. 115
Autologus stem cell transplantation as postremission therapy for acute myeloid leukemia. Risk factors at diagnosis can predict the outcome. 114
Granulocyte-macrophage colony -stimulating factor in acute nonlymphocytic leukemia before and after chemo therapy”. 114
Family history of cancer and risk of second malignancies in young cancer patients in Trieste, Italy. 113
B-cell immune reconstitution after allogenic stem cell transplantation and its role in the development of chronic graft-versus-host disease 113
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 113
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. 113
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. 113
Differences among young adults, adults and elderly chronic myeloid leukemia patients. 112
Pre-Chemotherapy risk factors for invasive fungal diseases: Prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (seifem 2010-a multicenter study) 112
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: A retrospective study from the Acute Leukemia Working Party of the EBMT 112
WHO classification and WPSS predict post-transplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 110
Best practice recommendations in: (1) Peripheral blood stem cell mobilization and collection and (2) acute and chronic GvHD treatment using extracorporeal photopheresis. A joint effort from SIdEM (Società Italiana di Emaferesi e Manipolazione Cellulare) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo). 110
Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation 110
P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia. 109
Longitudinal follow-up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogeneic bone marrow transplant 109
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. 109
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias 108
Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy 108
Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: A multicenter retrospective study based on donor availability 108
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers. 107
Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia 106
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome 106
Wilms' tumor 1 gene expression levels in acute promyelocytic leukemia compared to other acute myeloid leukemia subtypes 106
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study 106
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 105
Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey 105
ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia 105
“Case report: mdr-1 gene amplification in acute lymphoblastic leukemia prior to antileukemic treatment”. 105
CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma 104
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia 104
EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia. 104
Rituximab for the treatment of type II mixed cryoglobulinemia. 103
Paraneoplastic cerebellar degeneration associated with anti-neuronal anti-Tr antibodies in a patient with Hodgkin's disease 103
Response rate and survival after thalidomide-based therapy in 248 patients with myelodysplastic syndromes. 103
Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study. 103
Unexpected phenotype of a typical NPM1 mutant 103
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. 103
Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement 103
A comparison of allografting with autografting for newly diagnosed myeloma 102
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations. 102
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients 102
Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab. 101
Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera. 101
Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT 101
Leukaemic infiltration of the retina at onset of Philadelphia-positive acute lymphoblastic leukaemia revealed by stratus optical coherence tomography 101
Multipotent Mesenchymal Stem Cells Can Be Isolated and Grown from Many Tissues (Bone Marrow, Liver and Heart) 101
Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia 100
Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors. 100
Two cases of concomitant diffuse large B-cell lymphoma and myelodysplastic syndrome. 100
A phase II study of α-interferon and oral arabinosyl cytosine (YNK01) in chronic myeloid leukemia 100
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype 100
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia-- analysis of 848 patients 99
Surgical staging in Hodgkin's disease: the role of laparoscopic splenectomy 99
Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia. 99
Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma. 99
Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy 99
Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia 99
Totale 11.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.746
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.673 0 0 321 1.270 636 1.378 958 1.011 627 681 190 601
2020/20214.943 134 597 144 576 207 616 356 599 642 183 595 294
2021/20223.095 117 363 156 225 93 144 185 143 56 506 632 475
2022/20232.816 418 159 31 328 259 829 14 207 384 37 86 64
2023/2024853 122 66 27 27 132 100 17 53 142 65 32 70
2024/2025649 149 500 0 0 0 0 0 0 0 0 0 0
Totale 29.842